Testing evidenceNot available
0 accepted testing records were counted. Held and rejected records stayed out.
← Vendor directory
Profile needs more information
Oupeptide
We do not yet have enough testing and transparency information to assign a grade.
Not shortlist eligible at reviewComparable prices unavailable
Grade and evidence review: Sep 12, 2026.
Testing records00 distinct documents
Recorded offers0no comparable price observations
In-stock records0when observed; confirm with vendor
Evidence shortlists0Sep 12, 2026 review
How the grade was built · Sep 12, 2026
What we found and what is missing.
Transparency and support19 / 20
8 public identity, policy, catalog, or testing pages were successfully checked.
Catalog integrity9 / 30
Listing resolution, exact-basis coverage, freshness, and testing traceability contributed 9 points in the Sep 12, 2026 review.
Public discussion is context only and does not affect this score. Catalog integrity supplies the 30-point third component. Price updates do not change this dated grade.
Open the detailed evidence summary →Catalog and recorded prices
4 compounds connected to this vendor.
Catalog listings reflect the Sep 12, 2026 review. Price and stock observations can change; compare the exact product and confirm availability with the vendor.
| Compound | Catalog listings | Recorded offers | In stock when observed | Lowest effective price | That price observed | Compare |
|---|---|---|---|---|---|---|
| KLOW Blend (GHK-Cu/BPC-157/TB-500/KPV) | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Retatrutide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Semaglutide | 1 | 0 | Not recorded | Not available | Not available | View record → |
| Tirzepatide | 1 | 0 | Not recorded | Not available | Not available | View record → |